Search

everythinglearnresearchcommunity

for

Search:↓

sPLA2-IIE is crucial for normal hair follicle structure and skin health.

Caspase-7 has functions in skin and hair that are not related to cell death.

Researchers found genes linked to feather growth speed in Shouguang chickens, highlighting two genes that might explain differences in feathering.

Alopecia Areata is an autoimmune condition causing hair loss, influenced by genetics, environment, and possibly improved by anti-MIF therapy, with many patients experiencing regrowth within a year.

Targeting CXCL12 may help treat hair loss caused by androgens.

A parasite-derived molecule speeds up skin healing and affects immune cell behavior without increasing scarring.

Gene therapy shows promise for healing chronic wounds but needs more research to overcome challenges.

Efficient delivery systems are needed for the clinical use of CRISPR-Cas9 gene editing.

Coconut seed extract may effectively treat scabies in rabbits by killing mites and reducing inflammation.

Nonantibiotic macrolides show promise for treating various inflammatory skin conditions.

Men and women respond differently to drugs for COVID-19, high cholesterol, and diabetes, which suggests a need for personalized treatments.

Vitamin D receptor is crucial for skin wound healing.

Toothpaste containing α-tocopherol acetate, l-menthol, and stevioside can promote hair growth in mice.

Certain immune-related proteins are higher in people with alopecia and their healthy relatives, hinting at a genetic link.

Immune cells in Hidradenitis suppurativa become more inflammatory and may be important for treatment targets.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

The nervous system helps control stem cell behavior and immune responses, affecting tissue repair and maintenance.

A vitamin D receptor mutation causes rickets and affects immune responses.

The cause of Frontal fibrosing alopecia, a type of hair loss, is complex, likely involving immune responses and genetics, but is not fully understood.

A specific gene variant is linked to a higher risk of hair loss from chemotherapy in breast cancer patients.

Using healthy donor stem cells can potentially calm overactive immune cells and reduce inflammation in severe hair loss patients, offering a possible treatment method.

Advancements in nanoformulations for CRISPR-Cas9 genome editing can respond to specific triggers for controlled gene editing, showing promise in treating incurable diseases, but challenges like precision and system design complexity still need to be addressed.

Alopecia areata severity and treatment response are linked to specific cytokine levels.

Activating TLR9 helps heal wounds and regrow hair by using specific immune cells.

Liposomes show promise for delivering CRISPR for gene editing but face challenges like delivery efficiency and safety concerns.

Phosphorylation controls TFEB's location in the cell, affecting cell metabolism and stress response.

Stress may contribute to hair loss in alopecia areata by affecting immune responses and cell death in hair follicles.

Special particles from umbilical cord stem cells help heal skin wounds in diabetic mice by preventing certain immune cell death.

Denosumab, a bone loss treatment, may cause hair loss and skin reactions due to immune system effects.

AIRE deficiency causes hair loss similar to alopecia areata in mice.